Association of Early Same-Day Posttherapy Whole-Body SPECT/CT Using Visual RECIP 1.0 with Overall Survival During [ 177 Lu]Lu-PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer

医学 前列腺癌 内科学 肿瘤科 总体生存率 放射治疗 联想(心理学) 生存分析 前列腺 癌症 存活率 疾病 梅德林 比例危险模型 无进展生存期
作者
Hye Lim Park,David Kersting,Colin P. Bergstrom,Ali Raza Khaki,Jagruti C. Shah,Guido Davidzon,Farshad Moradi,Alice C. Fan,Sumit Anil Shah,Erin E. Grady,Sandy Srinivas,Andrei H. Iagaru,Song Hong
出处
期刊:Journal of nuclear medicine [Society of Nuclear Medicine and Molecular Imaging]
卷期号:67 (11): 1789-1796
标识
DOI:10.2967/jnumed.126.272651
摘要

This article evaluates whether early same-day posttherapy whole-body SPECT/CT assessed using visual RECIP 1.0 is associated with overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) that is positive for prostate-specific membrane antigen (PSMA) and treated with [177Lu]Lu-PSMA-617, and it assesses concordance among posttherapy SPECT/CT, PSMA PET/CT, and prostate-specific antigen (PSA). Methods: We retrospectively analyzed 158 men with mCRPC who received at least 2 cycles [177Lu]Lu-PSMA-617 between June 2022 and January 2025. Same-day posttherapy SPECT/CT was performed after each cycle. Early SPECT imaging response was assessed after cycle 2 using visual RECIP 1.0. Baseline tumor burden was classified as low or high volume using CHAARTED criteria on baseline SPECT. Early biochemical response was defined as a PSA decline of at least 50% (PSA50) before cycle 3. OS was the primary endpoint. Kaplan–Meier analysis, log-rank testing, and univariable and multivariable Cox regression were performed. Interim imaging response and concordance were evaluated for SPECT/CT and PSMA PET/CT after cycle 3. Results: Median follow-up was 23.9 mo, and median OS was 14.4 mo. Early SPECT response after cycle 2 was associated with longer OS than occurred with no response (21.5 vs. 11.3 mo, P < 0.001). High-volume baseline disease and absence of PSA50 were associated with shorter OS. The combination of imaging response, baseline tumor burden, and PSA50 improved survival stratification. Patients with high-volume disease and without imaging response were associated with the shortest OS compared with those with low-volume disease and imaging response (10.6 vs. 23.7 mo, P < 0.001). Among patients who underwent interim SPECT/CT and PSMA PET/CT (n = 97), progressive disease on either modality was associated with shorter survival. SPECT, PET, and PSA responses were concordant in 59.8% of patients. Discordant findings reflected differences in imaging timing, sensitivity, and biologic heterogeneity, including PSMA-negative disease. Conclusion: Early same-day posttherapy SPECT/CT assessed using visual RECIP 1.0 was associated with OS in patients with mCRPC who received [177Lu]Lu-PSMA-617. Integration of early SPECT response, baseline tumor burden, and PSA50 improved survival stratification. Substantial concordance among SPECT, PSMA PET, and PSA response, together with characteristic discordance patterns, supports a complementary role for SPECT/CT in treatment response assessment.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
无极微光的应助被海鲸采纳,获得20
1秒前
1秒前
荼蘼发布了新的文献求助10
3秒前
6秒前
Rui发布了新的文献求助10
6秒前
OVOV完成签到,获得积分10
7秒前
所所的应助被nini采纳,获得10
7秒前
橴钰完成签到,获得积分10
7秒前
8秒前
8秒前
Ran完成签到 ,获得积分0
8秒前
9秒前
9秒前
卡卡584完成签到,获得积分10
10秒前
10秒前
11秒前
12秒前
SciGPT的应助被皮不可采纳,获得10
12秒前
12秒前
荼蘼发布了新的文献求助10
12秒前
橴钰发布了新的文献求助30
13秒前
Rui完成签到,获得积分20
13秒前
13秒前
hhjj发布了新的文献求助10
13秒前
13秒前
汤圆完成签到,获得积分10
14秒前
Aihel发布了新的文献求助10
15秒前
卡卡584发布了新的文献求助10
15秒前
15秒前
16秒前
17秒前
18秒前
Serendipity发布了新的文献求助10
19秒前
汤圆发布了新的文献求助10
20秒前
海鲸发布了新的文献求助20
20秒前
在望的应助被肖馨余采纳,获得10
20秒前
爱撒娇的朋友完成签到,获得积分10
21秒前
烟花的应助被flash采纳,获得10
22秒前
积极亦竹发布了新的文献求助10
22秒前
xiaxi完成签到,获得积分10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175157
求助须知:如何正确求助?哪些是违规求助? 9566955
关于积分的说明 21789278
捐赠科研通 7769593
什么是DOI,文献DOI怎么找? 3431836
关于科研通互助平台的介绍 2556078
邀请新用户注册赠送积分活动 2477241